中文

迈普医学 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-28
ItemAmountY/Y
Revenue¥0.08B+6.3%
Gross profit¥0.06B
Operating income¥0.02B
Net income¥0.02B-14.3%
Gross margin78.8%Net margin 26.4%
Revenue Q/Q-34.5%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.02B21.2%
R&D¥0.01B11.2%
SG&A¥0.03B38.0%
Tax & other¥0.00B3.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

润丰股份双乐股份保立佳深水规院中集车辆中环海陆金百泽安联锐视绿岛风天禄科技能辉科技义翘神州

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies